A human seminoma xenograft model with regional lymph node metastasis

Journal of Urology

Volumn 161, Issue 1, 1999, Pages 342-348

  Konaka, Hiroyuki ^a   Koshida, Kiyoshi ^a   Endo, Yoshio ^a   Uchibayashi, Tadao ^a   Sasaki, Takuma ^a   Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Lymph node metastasis; Metastasis related genes; RT PCR; SCID mice; Seminoma

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; HISTOPATHOLOGY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SEMINOMA; XENOGRAFT;

EID: 0032877957     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62143-8     Document Type: Article

References (42)

1. Koshida, K., Yokoyama, K., Uchibayashi, T., Yamamoto, H., Hirano, K. and Namiki, M.: Factors contributing to imaging of xenografts using anti-placental alkaline phosphatase monoclonal antibody. J. Urol., 157: 1941, 1997.
2. Endo, Y., Sasaki, T., Harada, F. and Noguchi, M.: Specific detection of metastasized human tumor cells in embryonic chicks by the polymerase chain reaction. Jpn. J. Cancer Res., 81: 723, 1990.
3. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidmann, J. G. and Struhl, K.: Current Protocols in Molecular Biology, vol. 2. page A.1.5., John Wiley & Sons, Inc.: New York, p. A.1.5, 1990.
4. Chomczynski, P. and Sacchi, N.: Single step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
5. Ware, J. L. and Delong, E. R.: Influence of tumor size on human prostate tumor metastasis in athymic nude mice. Br. J. Cancer, 51: 419, 1985.
6. Nathanson, S. D., Haas, G. P., Med, M. J. and Lee, M.: Spontaneous regional lymph node metastases of three variants of the B16 melanoma: relationship to primary tumor size and pulmonary metastases. J. Surg. Oncol., 33: 41, 1986.
7. Koshida, K., Endo, Y., Kobayashi, T., Imao, T., Konaka, H., Kadono, Y., Uchibayashi, T., Sasaki, T. and Namiki, M.: Enhanced tumorigenic and metastatic potential of an androgen-sensitive human prostate cancer cell line, LNCaP, by intratesticular inoculation in SCID mice. Int. J. Oncol., 11: 513, 1997.
8. Koshida, K., Yokoyama, K., Imao, T., Konaka, H., Hirano, K., Uchibayashi, T. and Namiki, M.: Immunolocalization of anti-placental alkaline phosphatase monoclonal antibody in mice with testicular tumor and lymph node metastasis. Urol. Res., 26: 23, 1998.
9. Dinney, C. P. N., Fishbeck, R., Singh, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J. and Killion, J. J.: Isolation and characterization of metastatic variants from human transitional cell carcinoma passed by orthotopic implantation in athymic nude mice. J. Urol., 154: 1532, 1995.
10. Yashiro, M., Chung, Y. S., Nishimura, S., Inoue, T. and Sowa, M.: Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin. Exp. Metastasis, 14: 43, 1996.
11. Heiss, M. M., Babic, R., Allgayer, H., Gruetzner, K. U., Jauch, K. W., Loehrs, U. and Schildberg, F. W.: Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J. Clin. Oncol., 13: 2084, 1995.
12. Bouchet, C., Spyratos, F., Martin, P. M., Hacene, K., Gentile, A. and Oglobine, J.: Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br. J. Cancer, 69: 398, 1994.
13. Mueller, B. M., Yu, Y. B. and Laug, W. E.: Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc. Natl. Acad. Sci. USA, 92: 205, 1995.
14. Ishikawa, N., Endo, Y. and Sasaki, T.: Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer. Jpn. J. Cancer Res., 87: 480, 1996.
15. Nakamura, M., Konno, H., Tanaka, T., Maruo, Y., Nishino, N., Aoki, K., Baba, S., Sakaguchi, S., Takada, Y. and Takada, A.: Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thromb. Res., 65: 709, 1992.
16. Nagayama, M., Sato, A., Hayakawa, H., Urano, T., Takada, Y. and Takada, A.: Plasminogen activators and their inhibitors in non-small cell lung cancer. Cancer, 73: 1398, 1994.
17. Matrisan, L. M.: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121, 1990.
18. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G.: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327, 1991.
19. Montaegudo, C., Merino, M. J., San-Juan, J., Liotta, L. A. and Stetler-Stevenson, W. G.: Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol., 136: 585, 1990.
20. D'Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler-Stevenson, W. G. and Grigioni, W. F.: Augmentation of type IV collagenase, laminin receptor and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod. Pathol., 4: 239, 1991.
21. Stearns, M. E. and Wang, M.: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878, 1993.
22. Davies, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krausz, T., Neal, D., Thomas, D., Hanby, A. and Baikwill, F.: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53: 5365, 1993.
23. Autio-Harmainen, H., Karttunen, T., Hurskainen, T., Hoyhtya, M., Kauppila, A. and Tryggvason, K.: Expression of 72 kilo-dalton type IV collagenases (gelatinase A) in benign and malignant ovarian tumors. Lab. Invest., 69: 312, 1993.
24. Shima, I., Sasaguri, Y., Kusukawa, J., Yamana, H., Fujita, H., Kakegawa, T. and Morimatsu, M.: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. Cancer, 70: 2747, 1992.
25. Kusukawa, J., Sasaguchi, Y., Shima, I., Kameyama, T. and Morimatsu, M.: Expression of matrix metalloprotease-2 related to lymph node metastasis of oral squamous cell carcinoma. Am. J. Clin. Pathol., 99: 18, 1993.
26. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M.: A matrix metalloprotease expressed on the surface of invasive tumor cells. Nature, 370: 61, 1994.
27. Takino, T., Sato, H., Shinagawa, A. and Seiki, M.: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem., 270: 23013, 1995.
28. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y. and Seiki, M.: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer, 64: 355, 1995.
29. Plate, K. H., Breier, G. and Risa, U. W.: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 4: 207, 1994.
30. Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T. and Levi, B. Z.: Vascular endothelial growth factors and its receptors. Prog. Growth Factors Res., 5: 89, 1994.
31. Weindel, K.: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: key to angiogenesis. Neurosurg., 35: 439, 1994.
32. Takahashi, A., Sasaki, H., Kim, A. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T. and Terada, M.: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placental growth factor in renal cell carcinoma associated angiogenesis. Cancer Res., 54: 4233, 1994.
33. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., Senger, D. R., Connolly, J. L. and Schnitt, S. J.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in breast cancer. Hum. Pathol., 26: 86, 1995.
34. O'Brient, T., Cranston, D., Fuggle, S., Bicknell, R. and Harris, A. L.: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510, 1995.
35. Ohta, Y., Watanabe, Y., Oda, M., Hayashi, Y., Endo, Y. and Sasaki, T.: Vascular endothelial growth factor-121mRNA expression and neomicrovessel density in primary lung cancer. Oncol. Report, 3: 713, 1996.
36. Takahashi, Y., Kitadai, Y., Bucana, C. D., Clealy, K. R. and Ellis, L. M.: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964, 1995.
37. Viglietto, G., Romano, A., Maglione, D., Rambaldi, M., Paoletti, I., Lago, C. T., Monaco, C., Mineo, A., Santelli, G., Manzo, G., Botti, G., Chiappetta, G. and Persico, M. G.: Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene, 13: 577, 1996.
38. Fukuda, S., Shirahama, T., Imazono, Y., Nishiyama, K., Akiba, S., Akiyama, S., Ohmori, H., Tsushima, T. and Ohi, Y.: Overexpression of vascular endothelial growth factor (VEGF) in testicular germ cell tumors as an indicator of metastatic disease. J. Urol., 157: 188A, 1998.
39. Fidler, I. J.: Critical factors in the biology of human cancer metastasis. Cancer Res., 50: 6130, 1990.
40. Nip, J. and Brodt, P.: The role of the integrin vitronectin receptor, αvβ3 in melanoma metastasis. Cancer Metastasis Rev., 14: 241, 1995.
41. Tawil, N. J., Gowri, V., Djoneidi, M., Nip, J., Carbonetto, S. and Brodt, P.: Integrin α3β1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int. J. Cancer, 66: 703, 1996.
42. Kainz, C., Tempfer, C., Kohlberger, P., Janisch, S., Koelbel, H., Gitsch, G. and Breitenecker, G.: Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastasis of cervical cancer. Int. J. Cancer, 69: 170, 1996.